Researchers have discovered metabolic markers that forecast cancer patients' immunotherapy responses and survival outcomes, highlighting the...
Vous n'êtes pas connecté
In an innovative study published in a leading scientific journal, an international team of researchers led by Prof. Wangjun Liao from Nanfang Hospital, Southern Medical University has identified metabolic signatures that can predict immunotherapy response and survival outcomes in cancer patients. The study underscores the critical role of metabolic reprogramming in the tumour microenvironment and its [...]
Researchers have discovered metabolic markers that forecast cancer patients' immunotherapy responses and survival outcomes, highlighting the...
An innovative study helps identify metabolic signatures that can determine the survival chances of cancer.
A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...
Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system’s ability...
An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...
Researchers developed nanorobots that selectively kill cancer cells in mice. These robots deploy a concealed weapon activated only within the tumor...
Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from...
An international research team has discovered a new way to effectively treat cancer, by using nutrients to reactivate suppressed metabolic pathways in...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...
ImmunityBio (IBRX) rises 17% in the past week as it announces insurance coverage as well as the treatment of the first patients with its newly...